These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32383815)

  • 1. A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival.
    Bremer J; Kottke R; Johann PD; von Hoff K; Brazzola P; Grotzer MA; Kool M; Rushing E; Gerber NU
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28384. PubMed ID: 32383815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
    Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
    Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
    Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
    De Lima L; Sürme MB; Gessi M; Mastronuzzi A; Miele E; Tamburrini G; Massimi L
    Childs Nerv Syst; 2020 Aug; 36(8):1589-1599. PubMed ID: 32542405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases.
    Appay R; Macagno N; Padovani L; Korshunov A; Kool M; André N; Scavarda D; Pietsch T; Figarella-Branger D
    Am J Surg Pathol; 2017 Sep; 41(9):1254-1260. PubMed ID: 28704208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
    Paret C; Theruvath J; Russo A; Kron B; El Malki K; Lehmann N; Wingerter A; Neu MA; Gerhold-Ay A; Wagner W; Sommer C; Pietsch T; Seidmann L; Faber J
    Oncotarget; 2016 Dec; 7(50):83378-83391. PubMed ID: 27825128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
    Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
    Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade neuroepithelial tumor with BCL6 corepressor-alteration presenting pathological and radiological calcification: A case report.
    Ishi Y; Shimizu A; Takakuwa E; Sugiyama M; Okamoto M; Motegi H; Hirabayashi S; Cho Y; Iguchi A; Manabe A; Nobusawa S; Tanaka S; Yamaguchi S
    Pathol Int; 2021 May; 71(5):348-354. PubMed ID: 33713516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?
    Rao S; Mitra S; Sugur H; Vazhayil V; Rao BRM; Annayappa SK; Nandeesh BN; Yasha TC; Santosh V
    Brain Tumor Pathol; 2021 Jan; 38(1):41-49. PubMed ID: 32980923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients.
    Vewinger N; Huprich S; Seidmann L; Russo A; Alt F; Bender H; Sommer C; Samuel D; Lehmann N; Backes N; Roth L; Harter PN; Filipski K; Faber J; Paret C
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    Torre M; Meredith DM; Dubuc A; Solomon DA; Perry A; Vasudevaraja V; Serrano J; Snuderl M; Ligon KL; Alexandrescu S
    J Neuropathol Exp Neurol; 2019 Apr; 78(4):305-314. PubMed ID: 30816933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.
    Sugino H; Satomi K; Mori T; Mukai Y; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Yoshida A
    Brain Tumor Pathol; 2023 Apr; 40(2):133-141. PubMed ID: 36811792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA Sequencing.
    Al-Ibraheemi A; Putra J; Tsai HK; Cano S; Lip V; Pinches RS; Restrepo T; Alexandrescu S; Janeway KA; Duraisamy S; Harris MH; Church AJ
    J Mol Diagn; 2021 Oct; 23(10):1269-1278. PubMed ID: 34325058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case of the month 1-2019: CNS high-grade neuroepithelial tumor with
    Haberler C; Reiniger L; Rajnai H; Kalev O; Gelpi E; Tamesberger M; Pietsch T
    Clin Neuropathol; 2019; 38(1):4-7. PubMed ID: 30526817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Wound Site Seeding in a Patient with Central Nervous System High-Grade Neuroepithelial Tumor with BCOR Alteration.
    Kirkman MA; Pickles JC; Fairchild AR; Avery A; Pietsch T; Jacques TS; Aquilina K
    World Neurosurg; 2018 Aug; 116():279-284. PubMed ID: 29859355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication".
    Tauziède-Espariat A; Pierron G; Siegfried A; Guillemot D; Uro-Coste E; Nicaise Y; Castel D; Catalaa I; Larrieu-Ciron D; Chaynes P; de Barros A; Nicolau J; Gareton A; Lechapt E; Chrétien F; Bourdeaut F; Doz F; Bouchoucha Y; Grill J; Beccaria K; Boddaert N; Saffroy R; Pagès M; Varlet P
    Acta Neuropathol Commun; 2020 Nov; 8(1):178. PubMed ID: 33138864
    [No Abstract]   [Full Text] [Related]  

  • 17. A Cerebellar High-Grade Neuroepithelial Tumour with BCOR Alteration in a five-year-old Child: A case report.
    Al-Battashi A; Al Hajri Z; Perry A; Al-Kindi H; Al-Ghaithi I
    Sultan Qaboos Univ Med J; 2019 May; 19(2):e153-e156. PubMed ID: 31538015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma.
    Santiago T; Clay MR; Allen SJ; Orr BA
    Mod Pathol; 2017 Jun; 30(6):884-891. PubMed ID: 28256570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
    Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
    Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, pathological, and molecular features of central nervous system tumors with BCOR internal tandem duplication.
    Wang W; Zhang A; Li Y; Wang D; Chen L; Li Q; Chen J; Li H; Sun S; Pan M; Zhou W; Wu H
    Pathol Res Pract; 2024 Jul; 259():155367. PubMed ID: 38797130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.